Skip to main content

Table 2 Pre-RT blood cell data and clinical and pathological response in rectal cancer patients.

From: Circulating lymphocyte is an important determinant of the effectiveness of preoperative radiotherapy in advanced rectal cancer

Bloosd Cell data Non-CR (164) CR(15) p value  
Hb 12.8 ± 2.0 13.3 ± 1.1 NS  
WBC 6600 ± 2150 6370 ± 1510 NS  
   % neutrophil * 64.0 ± 9.5 57.8 ± 9.4 0.030  
   % eosinophil* 3.0 ± 2.8 2.2 ± 1.2 NS  
   % basophil * 0.5 ± 0.5 0.6 ± 0.4 NS  
   % monocyte * 6.8 ± 2.7 7.3 ± 3.0 NS  
   % lymphocyte* 25.6 ± 8.5 32.1 ± 9.5 0.011  
Platelet 27.9 ± 10.9 26.7 ± 8.4 NS  
  1. Each value is the mean ± SD before or after preoperative radiotherapy,
  2. Data were analysed using the Wilcoxon test.
  3. *: Data for white blood cell subsets after radiotheraopy were available in 168
  4. (CR15 and non-CR153) of 179 cases.